Heart :: Engineering the heart piece by piece
Some day, heart attack survivors might have a patch of laboratory-grown muscle placed in their heart, to replace areas that died during their attack.
Treatment
Preterm Birth :: Improving outcomes in premature births
The costs due to complications from preterm birth are staggering. In Canada, outlays for specialized care of surviving preterm infants are estimated to be almost $2 billion per year.
Tuberculosis :: WHO approves four new TB drugs made by Indian manufacturer
The United Nations health agency has approved four new drugs manufactured by generic producer Macleods of India for treatment of tuberculosis, with one of them being the first to be pre-qualified for strains resistant to standard treatment.
Healthcare :: Tailor-made information will help patients take control of their treatment
Doctors and other health professionals will prescribe information as well as pills under a new scheme launched by Health Secretary Patricia Hewitt in response to public demand.
Stem Cell :: Stem cells speed growth of healthy liver tissue
For the first time, researchers have used adult bone marrow stem cells to regenerate healthy human liver tissue, according to a study published in the April issue of the journal Radiology.
Lung Cancer :: Lung cancer screening regimen provides opportunity for cure
Annual computed tomography (CT) screening identifies a high proportion of patients with early-stage lung cancer, according to the latest findings of the New York Early Lung Cancer Action Project (NY-ELCAP) published in the April issue of the journal Radiology.
Lung Cancer :: RF ablation effective for treating inoperable lung cancer
A minimally invasive procedure known as radiofrequency (RF) ablation is effective for treating lung cancer in patients who are not candidates for surgery, according to a Rhode Island Hospital study published in the April issue of the journal Radiology.
Cholesterol :: Schering-Plough and Merck to develop new cholesterol lowering medicine
Schering-Plough Corporation (NYSE: SGP) announced that it has entered into an agreement with Merck & Co., Inc. to commence development of an ezetimibe and atorvastatin combination product.
Cholesterol :: CSL drug raises HDL good cholesterol, may reduce plaque in coronary arteries
CSL Limited announced results from a study published in the Journal of the American Medical Association that suggest infusions of a novel new drug, CSL-111, to acutely raise HDL (“good” cholesterol) levels, may reduce the amount of plaque in the coronary arteries of patients with a recent episode of acute coronary syndrome (ACS).
HIV :: Cornell researcher helping develop quick, cheap HIV AIDS test
A Cornell researcher is working to help develop a quick, simple and cheap immune-system test for people in the developing world. It could help HIV/AIDS sufferers in the poorest countries get appropriate treatment to extend their lives, possibly by as much as 10 to 15 years.